Pancreatic Neuroendocrine Neoplasm — Trials

Pancreatic Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

175 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02110563	Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma	terminated	Phase 1	50	Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyINDUSTRY	1	Jul 11, 2024	clinicaltrials
NCT00002947	Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer	terminated	Phase 1	35	Yale UniversityOTHER	1	Jul 2, 2014	clinicaltrials